Influenza virus-related critical illness: pathophysiology and epidemiology
André C. Kalil(Nebraska Medical Center), Paul G. Thomas(St. Jude Children's Research Hospital)
Cited by 509
Related Papers
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
|JAMA|2013|797
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial*
|Critical Care Medicine|2003|302
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3
|Arthritis & Rheumatology|2020|242
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1
|Arthritis & Rheumatology|2020|186
New advances in CMV and immunosenescence
|Experimental Gerontology|2014|149